Interferon‐Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection-Reference-Cited by-同舟云学术

Interferon‐Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection

Published:2019-06-21 Issue:5 Volume:70 Page:1506-1520
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Wrensch Florian¹²,Ligat Gaëtan¹²^ORCID,Heydmann Laura¹²,Schuster Catherine¹²,Zeisel Mirjam B.¹²³,Pessaux Patrick¹²⁴,Habersetzer François¹²⁴,King Barnabas J.⁵⁶,Tarr Alexander W.⁵⁶,Ball Jonathan K.⁵⁶,Winkler Michael⁷,Pöhlmann Stefan⁷⁸,Keck Zhen‐yong⁹,Foung Steven K.H.⁹,Baumert Thomas F.¹²⁴¹⁰

Affiliation:

1. Inserm, U1110 Institute for Viral and Liver Disease Strasbourg France

2. Université de Strasbourg Strasbourg France

3. Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon (CRCL) Université de Lyon (UCBL) Lyon France

4. Institut Hospitalo‐Universitaire, Pôle Hépato‐digestif Hôpitaux Universitaires de Strasbourg Strasbourg France

5. School of Life Sciences The University of Nottingham Nottingham United Kingdom

6. NIHR Nottingham BRC Nottingham University Hospitals NHS Trust and the University of Nottingham Nottingham United Kingdom

7. Infection Biology Unit German Primate Center–Leibniz Institute for Primate Research Göttingen Germany

8. Faculty of Biology and Psychology University of Göttingen Göttingen Germany

9. Department of Pathology Stanford University School of Medicine Stanford CA

10. Institut Universitaire de France Paris France

Funder

National Institute of Allergy and Infectious Diseases

Deutsche Forschungsgemeinschaft

H2020 European Institute of Innovation and Technology

H2020 European Research Council

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30699

Reference50 articles.

1. Curing Chronic Hepatitis C — The Arc of a Medical Triumph

2. A prophylactic hepatitis C virus vaccine: A distant peak still worth climbing

3. Treatment of hepatitis C in difficult-to-treat patients

4. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon-induced transmembrane protein-1 competitively blocks Ephrin receptor A2-mediated Epstein–Barr virus entry into epithelial cells;Nature Microbiology;2024-04-22

2. Investigating the impact of inflammatory response-related genes on renal fibrosis diagnosis: a machine learning-based study with experimental validation;Journal of Biomolecular Structure and Dynamics;2024-02-21

3. Role of Viral Envelope Proteins in Determining Susceptibility of Viruses to IFITM Proteins;Viruses;2024-02-05

4. MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets;Clinical Microbiology Reviews;2023-12-20

5. The Epigenetic Controller Lysine-Specific Demethylase 1 (LSD1) Regulates the Outcome of Hepatitis C Viral Infection;Cells;2023-11-03